Gene Query: KIAA0232

Dataset Description Geneva Score
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 41.91
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 38.02
mRNA recovered upon RNF219 IP. [RNA-IP] 34.68
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 31.62
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 31.16
HNRNPL and its RNA Targets in Prostate Cancer 31.16
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 30.7
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 30.62
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 29.41
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 27.05
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 23.74
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 22.7
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 22.47
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 20.58
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 19.38
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 19.31
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 18.93
RNA sequencing of matched nephrectomy samples [RNA-seq] 18.93
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 18.89
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 18.83
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 18.64
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 18.64
Genome wide expression change in LCC2 and MCF-7 cells 18.56
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 18.52
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 18.45
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 18.25
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 17.56
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 17.28
The regulartory role of ZCCHC24 in splicing machinery 16.87
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 16.27
RNAseq Analysis in glioblastoma cells treated with Mepazine 15.87
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 15.76
RNA-seq of tumor cells following angiopellosis extravasation 15.65
Dtx3L and Androgen Signaling in Prostate Cancer 14.81
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 14.5
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 14.2
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 13.95
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 13.86
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 13.77
Developmental stage specific chromosome architecture in human erythroid cells 13.57
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 13.57
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 13.42
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 13.07
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 12.86
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 12.77
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 12.77
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 12.49
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 12.43
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 12.37
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 12.34
Knockdown of ADNP in HCT116 colon cancer cells 11.8
Effect of CHKA knockdown on C4-2 cell transcriptome 11.7
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 11.64
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 11.64
Genes significantly down or Up-regulated upon RNF219 knockdown 11.61
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 11.48
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 11.22
A549 cells and MSR-A549 cells 11.2
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 11.2
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 11.15
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 11.05
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 10.87
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 10.87
Gene expression analysis of immortalized human liver progenitor-like cells in culture 10.86
Human neutrophil genome during PMA- and E. coli encounter-induced activation 10.77
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 10.77
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 10.77
Altering cancer transcriptomes using epigenomic inhibitors 10.77
BAF controls genome accessibility 10.77
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 10.75
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 10.63
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 10.52
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 10.44
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 10.4
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 10.35
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 10.32
RNA-seq analysis of differentiating human erythroblasts 10.25
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 10.24
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 10.24
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.16
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 10.13
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 10.13
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 10.13
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 10.12
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 10.01
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 10.01
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.96
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 9.86
LINE-2 transposable elements are a source of functional human microRNAs and target sites 9.82
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 9.82
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 9.82
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 9.81
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 9.68
DJ-1 is dispensable for human stem cell homeostasis 9.65
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 9.61
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 9.58
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 9.55
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 9.47
Irf9 function in immunity in mouse 9.47
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 9.35
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 9.35
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 9.32
RNA-seq analyses of human prostate cancer cells 9.25
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 9.2
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 9.19
Uridylation by TUT4 and TUT7 marks mRNA for degradation 9.16
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 9.16
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 9.1
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 9.05
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 9.01
Lineage specific differentiation is influenced by state of human pluripotency 9.01
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 9.01
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 8.8
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 8.74
Impact of dieldrin on transcription in Jurkat T cells 8.68
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 8.66
Differential analysis of gene regulation at transcript resolution by RNA-Seq 8.65
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 8.65
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 8.61
LIN28A modulates splicing and gene expression programs in breast cancer cells 8.59
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 8.59
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 8.56
Examining serotonergic neuron differentiation from human iPSCs 8.51
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 8.51
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 8.48
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 8.48
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.47
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 8.47
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 8.46
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.42
Gene expression changes associated with resistance to tagraxofusp (SL-401) 8.41
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 8.29
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 8.28
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 8.28
Human embryonic stem cells in E8 and AKIT culture medium 8.28
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 8.26
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.22
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 8.22
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 8.22
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 8.19
An siRNA screen identifies CHD4 as a target for epigenetic therapy 8.19
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 8.17
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.14
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.14
EP400 is required for Max and MCPyV mediated gene activation 8.13
LncRNA expression profiling of ischemic stroke patients 8.11
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 8.11
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 8.09
Lipid degradation promotes prostate cancer cell survival 8.03
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 8.0
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 7.99
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 7.98
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 7.97
IMP3 regulated gene expression in breast cancer cells 7.95
Differential gene expression of human melanoma cells [RNA-seq] 7.86
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.86
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 7.85
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 7.8
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.77
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 7.7
RNAseq analysis of ESRP regulated splicing events in prostate cancer 7.69
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.68
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.68
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 7.64
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 7.63
Real-time observation of light-controlled transcription in living cells 7.61
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 7.55
RNA-sequencing of human tendon after injury 7.55
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.39
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 7.35
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 7.35
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 7.34
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 7.29
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 7.28
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 7.27
Global Mapping of Human RNA-RNA Interactions 7.26
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 7.26
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 7.23
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 7.21
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 7.2
Ribosomal footprinting of CN34-Parental and CN34-LM1a 7.2
Effect of Hotair overexpression in human breast cancer cell lines 7.2
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 7.12
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 7.07
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 7.07
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 7.05
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 7.05
Gene expression profiling of leukemia cells following asparagine depletion 7.01
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 6.98
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 6.97
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 6.96
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 6.96
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 6.92
Effect of disulfiram treatment on pediatric high grade glioma 6.88
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.86
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 6.81
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 6.79
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 6.76
RNA sequencing of BT142 and TS603 cell lines 6.72
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 6.72
Noncoding regions are the main source of targetable tumor-specific antigens 6.72
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 6.71
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 6.65
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 6.64
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 6.64
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 6.62
Dysregulated immune system networks in war veterans with PTSD 6.59
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.59
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 6.59
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.57
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 6.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 6.52
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 6.51
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 6.51
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 6.48
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.47
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.47
Interphase condensins regulate ligand-depedent enhancer activation 6.46
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 6.46
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.45
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 6.43
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 6.41
Human HAP1 cells before and after nutrient deprivation 6.41
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.41
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.4
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.4
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 6.37
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 6.33
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 6.31
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 6.26
Novel Targeting of Transcription and Metabolism in Glioblastoma 6.26
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.23
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 6.19
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 6.19
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 6.19
Genetic-to-epigenetic Therapy for Pancreatic Cancer 6.17
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 6.11
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 6.11
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.11
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 6.09
Next generation sequencing of small RNAs isolated from exosomes in human semen 6.07
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 6.04
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 6.03
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.0
Identification of global XBP1s target gene expression in human prostate cancer cells 5.92
NAPRT activation of macrophages 5.92
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.92
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 5.89
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 5.88
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.88
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 5.86
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 5.86
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 5.82
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 5.82
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.81
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 5.78
Global response to chemotherapy-induced apoptosis 5.73
CD73 knockdown effect in pancreatic cancer cell lines 5.73
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 5.72
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 5.67
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 5.65
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 5.64
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 5.58
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 5.54
Neonatal and adult human testis defined at the single-cell level 5.54
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 5.52
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 5.52
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.48
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.47
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 5.47
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 5.47
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 5.4
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 5.37
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 5.33
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.24
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.12
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 5.08
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 5.08
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.05
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.05
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 5.04
Searching for target genes of miR-508/509/506/514 in HCT116 cells 5.04
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 5.03
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.0
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 4.98
A map of gene expression in neutrophil-like cell lines 4.93
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.87
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 4.75
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 4.75
Aneuploidy triggers an immune response 4.73
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 4.72
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 4.7
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 4.67
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.66
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.66
Transcriptome of diurnal human blood neutrophils 4.65
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 4.6
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.55
RNA-seq analysis of control and Myc-induced U2OS cells 4.52
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.5
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.5
Gene expression profile of human iPSC-derived nephron progenitor cells 4.47
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 4.42
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 4.39
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 4.36
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.35
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.28
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 4.22
RNA-seq of shEZH2 cells 4.18
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 4.13
Hepatitis C virus functionally sequesters miR-122 4.11
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.11
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.05
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.04
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 4.03
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 4.02
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.02
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 4.0
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.0
Transcriptome analysis of peripheral blood monocytes 3.99
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.9
6mer seed toxicity in tumour suppressive microRNAs 3.83
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.83
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 3.81
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.79
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 3.78
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.77
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.77
Primate transcript and protein expression levels evolve under compensatory selection pressures 3.72
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.72
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.71
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.67
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.67
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 3.66
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 3.64
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.55
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.52
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.52
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 3.5
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.44
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 3.42
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 3.41
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.36
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.35
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.35
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.33
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 3.32
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.28
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 3.26
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 3.26
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.25
KSDM1b Role in Ewing Sarcoma 3.19
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.19
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.17
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.15
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.13
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 3.1
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.1
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.07
Determining mRNA half-lives on a transcriptome-wide scale 3.04
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 3.03
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.02
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.94
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 2.94
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.91
m6A-dependent regulation of messenger RNA stability 2.86
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.85
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 2.85
Transcriptomic analysis of ERR alpha orphan nuclear receptor 2.79
Transcriptomic analysis of LSD1 2.77
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.72
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.72
SOX11 knockdown in B-ALL cell lines 2.71
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.69
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.69
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.67
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 2.66
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 2.66
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 2.64
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.62
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.62
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.6
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.56
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.5
The transcriptome of Kawasaki Disease arteritis 2.49
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 2.46
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.38
Gene expression and genome-wide location analysis of breast cancer cell-lines 2.38
Gene expression analysis of breast cancer cell-lines 2.38
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.33
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.32
Loss of endometrial plasticity in recurrent pregnancy loss 2.32
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.31
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.25
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.2
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.18
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.18
RNA Sequencing of Human iPS derived Cardiomyocytes 2.13
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 2.1
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.09
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.06
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.02
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.02
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 1.99
The cohesin release factor WAPL restricts chromatin loop extension. 1.99
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 1.98
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.87
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.84
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.84
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.8
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.8
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.8
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.78
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.76
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 1.74
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.72
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.63
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.61
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.6
RNA-sequencing 1.59
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.59
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.51
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.51
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.48
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.48
Changes in human endometrial gland transcriptome over the window of implantation 1.47
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.47
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.42
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 1.41
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 1.41
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 1.41
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.4
Dilated cardiomyopathy vs Myocarditis 1.31
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.3
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.29
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.28
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 1.28
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.26
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 1.26
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.25
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.24
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.23
Interaction between mitoNEET and NAF-1 in cancer cells 1.18
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.16
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 1.07
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.03
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.03
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.96
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.93
MRTF activates TEAD-YAP target gene expression 0.92
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.88
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.85
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.84
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.84
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.81
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.78
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.77
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.76
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.74
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.74
Impact on erythroid progenitor type on erythroid differntiation 0.74
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.73
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.73
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.7
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.65
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.65
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.65
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.62
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.62
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.56
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.54
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.52
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.51
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.45
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.42
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.38
Zika virus directly infects human peripheral neurons and induces cell death 0.38
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 0.37
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.36
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.36
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.35
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.35
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.35
High-resolution comparative analysis of great ape genomes 0.34
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.33
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.33
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.33
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.28
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.27
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.24
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.24
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.16
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.12
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.11
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.1
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.1
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.09
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.04
Expression analysis of the TAF1 syndrome 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation